Per Løgstrup Poulsen Selected Research

Per Løgstrup Poulsen Research Topics

Disease

8	Type 2 Diabetes Mellitus (MODY) 12/2021 - 05/2007
5	Neoplasms (Cancer) 01/2022 - 10/2016
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 12/2011
3	Cushing Syndrome 01/2022 - 01/2014
3	Paraganglioma (Paragangliomas) 01/2021 - 01/2017
2	Pheochromocytoma 01/2021 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 11/2014
2	Hypertension (High Blood Pressure) 12/2017 - 11/2014
2	type 1 familial Hypocalciuric hypercalcemia 10/2016 - 10/2016
2	Albuminuria 11/2014 - 06/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2011 - 10/2003
1	Hypokalemia 05/2022
1	Ischemic Stroke 12/2021
1	Myocardial Infarction 12/2021
1	Hyperemia 01/2019
1	Insulinoma 04/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Essential Hypertension 12/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2017
1	Primary Hyperparathyroidism 10/2016
1	Hypercalcemia (Milk Alkali Syndrome) 10/2016
1	Hypothyroidism 01/2016
1	Thyroid Neoplasms (Thyroid Cancer) 01/2016
1	Ventricular Fibrillation 12/2014
1	Heart Arrest (Cardiac Arrest) 12/2014
1	Hyperinsulinism (Hyperinsulinemia) 12/2013
1	Hyperglycemia 12/2013
1	Muscular Diseases (Myopathy) 08/2009
1	Hearing Loss (Hearing Impairment) 08/2009
1	Noninsulin-dependent diabetes mellitus with deafness 08/2009
1	Acromegaly 03/2007
1	Macular Edema 10/2006
1	Macular Degeneration (Age-Related Maculopathy) 10/2006
1	Critical Illness (Critically Ill) 10/2003
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2002
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 04/2002

Drug/Important Bio-Agent (IBA)

5	Retinaldehyde (Retinal)IBA 01/2019 - 10/2006
5	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 12/2002
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 08/2009
3	CatecholaminesIBA 01/2021 - 01/2017
2	C-Reactive ProteinIBA 01/2019 - 11/2014
1	PotassiumIBA 05/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 05/2022
1	GTP-Binding Proteins (G-Protein)IBA 05/2022
1	Potassium Chloride FDA LinkGeneric 05/2022
1	GlucocorticoidsIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 12/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	salicylhydroxamic acid (SHAM)IBA 12/2017
1	Dihydroxyphenylalanine (Dopa)IBA 01/2017
1	Edotreotide (SMT 487)IBA 01/2017
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2017
1	Colloids (Colloid)IBA 01/2017
1	Calcium-Sensing ReceptorsIBA 10/2016
1	Parathyroid Hormone (Parathormone)IBA 10/2016
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2016
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2016
1	MineralocorticoidsIBA 12/2014
1	AlbuminsIBA 11/2014
1	Hemoglobins (Hemoglobin)IBA 10/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2014
1	Extracellular Matrix ProteinsIBA 07/2013
1	ElastinIBA 07/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2011
1	Amlodipine (Norvasc)FDA LinkGeneric 12/2011
1	Lisinopril (Prinivil)FDA LinkGeneric 12/2011
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2011
1	Mitochondrial DNA (mtDNA)IBA 08/2009
1	Proteins (Proteins, Gene)FDA Link 05/2007
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2007
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 10/2003
1	Insulin (Novolin)FDA Link 10/2003

Therapy/Procedure

3	Therapeutics 01/2021 - 12/2002
1	Aftercare (After-Treatment) 01/2022
1	Metastasectomy 01/2022
1	Continuous Positive Airway Pressure 01/2021
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 04/2018
1	Denervation 12/2017
1	Parathyroidectomy 10/2016
1	Lasers (Laser) 10/2006
1	Adrenalectomy 04/2002